Hypercalcemia is a common complication of malignant diseases with or without bone metastasis. Hypercalcemia in prostate cancer is rarely seen. The exact mechanism of prostate cancer-related hypercalcemia is still uncertain. Secretion of parathyroid hormone-related peptides (PTH-rP) is thought to be one of the possible mechanisms. We reported a rare case of prostate cancer with hypercalcemia (13 mg/dL). Bone marrow biopsy showed metastatic adenocarcinoma. The cells were also positive for neuron-specific enolase, which is the specific marker for neuroendocrine cell. The finding suggested that the prostate cancer cell derived from the neuroendocrine cell, which might synthesize PTH-rP and be responsible for the observed hypercalcemia.
CITATION STYLE
Wu, C. H., Lan, Y. J., Wang, C. H., & Wu, M. S. (2004). Hypercalcemia in prostate cancer with positive neuron-specific enolase stain. Renal Failure, 26(3), 325–327. https://doi.org/10.1081/JDI-200026727
Mendeley helps you to discover research relevant for your work.